Estimating disease risk during international travel is complicated by the lack of a representative denominator, loss to follow-up, underreporting, and selection bias. Although several strategies for risk estimation have been employed (case series, cross-sectional airport surveys, prospective cohorts), each has its own set of limitations [1] .
The GeoSentinel Surveillance Network was established in 1995 by the International Society of Travel Medicine and the US Centers for Disease Control and Prevention [2] . It is a global provider-based network of travel medicine clinics recruited to conduct surveillance of morbidity among international travelers. GeoSentinel data are limited in estimating travel-related disease risk primarily because only ill patients with a presumed travel-related illness are captured. Nevertheless, these data have been useful for understanding disease patterns in travelers, the development of pretravel counseling guidelines [3] , and the medical evaluation of the ill traveler [4, 5] .
GeoSentinel analyses have mostly relied on proportionate morbidity (PM) [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] , or the number of travelers diagnosed with the disease of interest divided by the total number of ill travelers reported. A χ 2 test is often used to detect differences in PM between groups [6-9, 11, 14] and a proportionate morbidity ratio (PMR) is sometimes calculated comparing exposed and unexposed groups. The PMR (approximated with an odds ratio [OR] ) has been used in GeoSentinel to examine aspects of the surveillance data, including associations between travel destination and the probability of returning ill with a specific disease [9] [10] [11] [12] [13] [14] .
However, the PMR has disadvantages. Because GeoSentinel collects data on ill travelers only, the PMR cannot be used to estimate disease risk. It is also prone to distortion by the numerator's influence on the denominator [16] . While the exposure of interest may increase the number of ill patients in the numerator, it may also decrease the number of ill patients in the denominator. Finally, the PMR requires stringent assumptions to be an estimate of the risk ratio (RR): the sum of the morbidity rate of the disease of interest and the morbidity rate in the auxiliary group (the other diseases) must be equal among the exposed and unexposed [17] . In other words, the exposure must not be associated with the total morbidity rate. This assumption is reasonable with PMR only when the exposure of interest is rare in relation to other exposures.
Rothman has suggested applying the principles of a casecontrol design to the analysis of surveillance data to calculate a reporting odds ratio (ROR) [16] , rather than a PMR. The ROR requires less stringent assumptions to estimate the RR. Specifically, the rate of morbidity for the auxiliary group must be the same among the exposed and unexposed. Further, the exposure must not be associated with the selection of controls, a key principle of control selection in case-control studies. As such, the ROR may be a more robust measure of association for analytical studies using surveillance data. Applying this method requires accurate selection of controls to represent the distribution of exposure in the base population and use of a strict case definition.
Over the past several years, the number and diversity of records in the GeoSentinel database have grown exponentially. This growth recently reached a point sufficient to allow for the exploration of alternate analytic techniques that might go beyond the limitations of PMR. To that end, we evaluated the performance of the case-control design, calculating RORs in a single-syndrome analysis of GeoSentinel data. We hypothesized that a case-control design with carefully defined cases and thoughtfully selected controls, controlling for GeoSentinel site and date of clinic visit as potential confounders, would generate more valid estimates of association than a PM design. Specifically, we compared a matched case-control design with restricted control selection, an unmatched case-control design with restricted control selection, an unmatched case-control design using all noncases as controls, and a PM design, measuring the association between region of travel and acute gastrointestinal illness (AGI).
METHODS

Data Collection
All GeoSentinel sites use a standard reporting form to collect anonymous data on ill travelers seen during and after international travel (Supplementary Appendix A). Data collected include demographics, travel history, travel purpose, pretravel medical advice, inpatient or outpatient status, clinical symptoms, final diagnoses, and country of acquisition of the main final diagnosis, as determined by a physician. Diagnoses are selected from a standard list of >500 diagnostic codes, grouped into 21 broad syndrome categories (Supplementary Appendix B). Individual patient records can include multiple diagnoses. Data, compiled at a central site, were extracted. This analysis was determined to be nonresearch by the Centers for Disease Control and Prevention's human subjects advisors.
Initial Exclusion Criteria
All travelers seen at a GeoSentinel clinic from January 1995 through August 2011 were eligible for inclusion. Excluded were patients seen during travel, inpatients, individuals who underwent screening for travel-related diseases, persons diagnosed with conditions related to their immigration, and patients found to have conditions not related to travel. Records with missing age, missing exposure region, and missing or "suspected" final diagnosis were excluded.
Exposure and Outcome Definitions
The exposure of interest was region of travel defined using 2 approaches. We used the GeoSentinel region definitions [2] to group countries geographically. Additionally, we used 2009 World Bank income levels [18] to define countries economically as low-income, low-middle-income, upper-middle-income, and high-income destinations. A case patient was defined as an ill person with at least 1 of 34 AGI diagnoses (Supplementary Appendix C) with an accompanying gastrointestinal symptom. Potential cases were excluded if there was an additional diagnosis of human immunodeficiency virus (HIV)/AIDS, Crohn's disease, new-onset irritable bowel disease, or pregnancy with a nonpathogenic case diagnosis (eg, Entamoeba coli).
Statistical Analyses
We conducted analyses using 4 different comparison groups, as described below. Additional covariates included in all models were age, sex, travel purpose, and expatriate status. A 2-sided P value <.05 was considered significant. SAS software version 9.3 (SAS Institute, Cary, North Carolina) was used for all analyses.
Analysis 1: Matched Case-Control With Restricted Control Selection
We used a matched case-control design for 3 reasons. First, we designated GeoSentinel site and date of clinic visit a priori as potential confounders; matching on these 2 characteristics was considered to be an efficient way to achieve control of any inherent confounding. Second, we matched to improve statistical efficiency. Third, we used this matched design to approximate a multisite study where each case is analyzed with respect to a control from its base population. We defined our base population as international travelers who would have visited a GeoSentinel clinic and been subsequently diagnosed with AGI had they contracted an AGI from January 1995 through August 2011.
Potential restricted controls for the case patients were a subset of other ill persons reporting to the respective GeoSentinel clinic within 1 month. The goal of such selection was to choose ill travelers who represent the exposure distribution among the base population from which the cases arose. In choosing controls, we first evaluated each syndrome group in GeoSentinel (Supplementary Appendix D). We considered which groups of travelers would be most representative of the base population using factors such as travel behavior, travel type, timing of diagnosis and presentation at the clinic, referral patterns, and assurance that the diagnosis was actually travel related. We then evaluated specific diagnoses within the chosen syndrome groups. Eligible restricted controls included those with specific diagnoses in 1 of the following syndrome groups: respiratory illness, febrile illness, and dermatologic conditions. Supplementary Appendix E has a complete list of control diagnoses. To reduce misclassification, the control group excluded (1) any patient with multiple diagnoses who had a case diagnosis but was not eligible to be a case (eg, no gastrointestinal symptom), (2) those with additional diagnoses in the chronic diarrhea or other gastrointestinal syndrome group, (3) those presenting with gastrointestinal symptoms, (4) those with a diagnosis of HIV/AIDS, and (5) those with an unascertainable exposure region.
Each case patient was matched on GeoSentinel site and date of clinic visit (±2 weeks) to 1 restricted control using the Greedy matching macro [19] . RORs on matched cases and controls were calculated using conditional logistic regression and tested using McNemar (Mantel-Haenszel) test statistic.
Analysis 2: Unmatched Case-Control With Restricted Control Selection
Although this design used restricted controls, case patients were not matched to a control. RORs were calculated using logistic regression and tested using a χ 2 test.
Analysis 3: Unmatched Case-Control Using All Noncases as Controls
This design did not utilize restricted controls; instead it used all non-case patients who reported posttravel to a GeoSentinel clinic in the denominator and total cases in the numerator. RORs were calculated using logistic regression and were tested by using a χ 2 test.
Analysis 4: Proportionate Morbidity
The PM analysis included total cases in the numerator and total cases plus noncases that met our initial inclusion criteria for the denominator (Figure 2) . A PM analysis was conducted to produce PMRs using log binomial models. PMRs were tested with χ 2 tests.
RESULTS
After initial exclusions, 42 422 patients were eligible for analysis ( Figure 1 ): 9847 AGI case patients and 32 219 non-case patients. Applying a strict control definition resulted in 17 521 restricted control patients. Matching case patients to restricted controls by GeoSentinel site and date of clinic visit resulted in 8486 matched pairs (86% match rate). A total of 42 066 patients were included in the PM denominator ( Figure 2 ). Most travelers visited South-Central Asia, sub-Saharan Africa, and Southeast Asia and countries in the low-middle income regions ( Table 1 ). The most common case diagnoses among matched case patients were "diarrhea, acute unspecified" (33.2% of case diagnoses), "diarrhea, acute bacterial" (14.9%), Giardia (14.9%), Campylobacter (7.1%), and gastroenteritis (7.1%). Table 2 shows results from all analyses exploring the association between geographic region of exposure and AGI. Compared with Western Europe and North America, each design shows that the association was greatest among those who traveled to North Africa, followed by South-Central Asia and the Middle East. To evaluate confounding by the matching variables, we compared the fully adjusted matched ROR (analysis 1) to an unmatched ROR in which GeoSentinel site and date of clinic visit were not controlled (analysis 2). We found that, except for the Caribbean, Central America, and Eastern Europe, the RORs fell within 10% of the gold standard. We also found the confidence intervals of the matched analysis (analysis 1) to be slightly wider than those of an unmatched analysis with restricted controls adjusted for all covariates including GeoSentinel site and date of clinic visit (data not shown). Compared to the unmatched RORs with unrestricted controls (analysis 3) and the PMRs (analysis 4), the majority of unmatched RORs with restricted controls (analysis 2) were further from the null. There was consistency in the magnitude of the matched ROR (analysis 1) and PMR (analysis 4) in some regions such as the Caribbean (ROR = 1.79, PMR = 1.60). However, in other regions, the matched ROR was noticeably different than the PMR, including North Africa (ROR = 7.89, PMR = 3.23) and South-Central Asia (ROR = 6.06, PMR = 3.02), where there was almost a 2-fold difference in the measure of association.
Analysis of World Bank income-defined destinations and AGI found the association to be greatest among those who traveled to a low-middle income destination (Table 3 ). To evaluate confounding by the matching variables, we compared the fully adjusted matched ROR (analysis 1) to the unmatched ROR in which GeoSentinel site and date of clinic visit were not controlled (analysis 2). All of the RORs fell within 10% of the gold standard. Confidence intervals of the matched analysis (analysis 1) were slightly wider than those of an unmatched analysis with restricted controls adjusting for all covariates including GeoSentinel site and date of clinic visit (data not shown). Compared to the unmatched RORs with unrestricted 
DISCUSSION
Although our results showed some consistency between the ROR and PMR, there were differences between the 2 measures of association among some geographic regions of the world (North Africa, South-Central Asia). For single-syndrome analyses of GeoSentinel analyses, the ROR may be the preferred measure of association, especially when controls are carefully selected to best represent a defined base population.
The ROR has advantageous statistical properties compared with the PMR [16, 17] . It is not distorted by the numerator and denominator, and requires less stringent assumptions to be an approximation of the RR. By using the ROR, we potentially remove 2 sources of bias [16] . First, restricted controls were selected based on factors potentially responsible for the nonrepresentativeness of the exposure distribution in a control population. PMR and nonrestricted control methods employed in GeoSentinel analyses do not attempt to identify and adjust for categories responsible for these differences, nor do they define a base population. Second, the bias stemming from the inclusion of cases in the denominator of the PMR is completely removed by using the ROR, especially as AGI cases make up a large proportion of diagnoses among returned travelers (34%) in the GeoSentinel database [4] .
We do not hypothesize that the ROR in this study is a direct approximation of the RR. Without the rare disease assumption, the OR in a case-control study can approximate the RR when the following conditions are met: (1) the controls are randomly sampled from the entire cohort and (2) the controls are sampled to have the same exposure distribution as the source population. Most ill travelers attending a GeoSentinel clinic would likely have an illness associated with a region of travel; thus, controls might not have been selected independent of exposure and may not have the same exposure distribution as the source population.
It is possible that none of the measures of association calculated estimate the true measure of RR. RORs from the unmatched and matched case-control analyses, both with restricted controls, were consistently farther from the null than PMRs, suggesting that analyses using all noncases as controls potentially underestimate the measure of association. However, because exposure was associated with selection into the matched study, the ROR could be biased toward the null. It is also known that ORs will be further from the null than the RR if the disease is not rare, which may be the case for AGI.
Matching by GeoSentinel site and date of clinic visit addresses intersite differences in patient populations, data collection procedures, and provider practice. Matching helps to meet the principles of study base, control for confounding, and comparable accuracy in case-control studies [20] . Comparing the matched to the unmatched analysis, both with restricted controls, there were differences of >10% in some geographic regions, indicating that confounding by GeoSentinel site and date of clinic visit may exist. Matching on these variables also ensures that staffing turnovers or changes in procedures would not have a great effect on data collection or diagnosis. Matching did not definitively improve statistical efficiency in this cohort, as the matched confidence intervals were wider than the unmatched. However, this may reflect the fact that the unmatched analysis includes more observations because concordant pairs and those that did not match are discarded in a matched analysis [21] . In analyses of less common diagnoses in GeoSentinel, matching may provide clearer gains in statistical efficiency. Although it may not necessarily improve the validity of the results, matching by GeoSentinel site and date of clinic visit may simulate a multicenter case-control study. This ensures that each case is analyzed in relation to a control from its base population during the same time period.
We maintain that in GeoSentinel analyses, all steps should be taken to define a base population, and controls should be selected to maximally represent the exposure distribution in the base population. Studies of other GeoSentinel diagnoses may result in more or less marked differences between analysis techniques, and we cannot know if the matched ROR is closer to the true RR than the PMR. Nevertheless, there were differences in the magnitude of the ROR and PMR for several geographic regions of the world, which may affect the recommendations for prevention of AGI that providers communicate to travelers. Even if we do not know the true RRs, we can reason through epidemiologic theory that a case-control design with thoughtful selection of controls may produce improved accuracy of the estimates of association. The GeoSentinel surveillance system provides a powerful dataset for the evaluation of travel-related morbidity. It has allowed for the description of disease among specific travel types [5, 11, 22] , among persons traveling to specific international destinations or events [23] , according to region of travel [6] , and the evaluation of associations with single diseases [8, [24] [25] [26] . After exploring the relationship between AGI and region of travel, we conclude that a case-control study with thoughtful case and control definition and controlling for GeoSentinel site and date of clinic visit may be preferred for singlesyndrome analytical studies using GeoSentinel data. Matching may be used to control for confounding, improve statistical efficiency, and simulate a multicenter study by employing proper control methods in the analysis. However, other analytic techniques to control for confounding exist and should be explored in future GeoSentinel analyses. Although none of the measures of association presented in this context meet the assumptions required to approximate a measure of RR, the ROR has superior statistical properties compared to the PMR in such studies. Furthermore, the case-control design involved the development of a base population with thoughtful selection of control. We note the limitations of using GeoSentinel data for analytical purposes and propose a case-control design with carefully defined cases and thoughtful inclusion criteria for the controls as a practical analysis option. This method of analysis may be used with GeoSentinel data exploring additional disease outcomes and other types of surveillance data.
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